Background: AGEs are formed under oxidative conditions and are called advanced glycoxidation end products. Periodontitis is a multifactorial inflammatory condition. The periodontal tissue damage is caused directly by bacteria and indirectly by inflammation and immunologic response against the bacteria. This inflammatory response is characterized by generation of prolonged release of neutrophil proteolytic enzymes, pro-inflammatory mediators and reactive oxygen species (ROS). Therefore, periodontitis is strictly linked to numerous pathologies which are related to production of oxidative stress and AGEs.
INTRODUCTION
Advanced glycation end products are a complex and heterogeneous group of compounds which are produced by the non-enzymatic and spontaneous reactions of the carbonyl group of carbohydrates with proteins, nucleic acids or lipids through a series of reactions. Actually, this process is composed of two steps: i) The condensation of a sugar aldehyde with a free amino group of proteins (usually hydroxyllysine or arginine residues) forming a non-stable Schiff base ii) Formation of Amadori products from Schiff base. This glycation process, which is also known as the Millard action, was described in the early 1912's by Louis-Camille Maillard. The Schiff base and especially Amadori products may undergo oxidation, dehydration, and polymerization to rise other AGEs. The AGEs that formed under oxidative conditions are called advanced glycoxidation end products (Goldin et al, 2006) .
Chronic disorders are significantly accompanied with oxidative stress in humans and animals, as decreased expression of anti-oxidative enzymes along with NADPH oxidase activation, all contribute to the high production of ROS in the tissues. Activation of nuclear factor (NF)-κB, and JNK pathways is accompanied by obesity, high-fat diet, and cellular stresses (ROS), which have the ability to increase the inflammatory responses in body tissues. Some ligands including TNFR, IL-1R, and RAGE that are receptors for TNF-α, IL-1, and AGEs can also activate the JNK pathway during metabolic dys-regulation (Shoelson et al, 2006) . These processes that are occurred in diseases are the principal causative factors for the formation of AGEs (Elaheh et al, 2018) .
Periodontitis is considered as a multifactorial condition that is caused by infection with pathogenic bacteria and significantly modified by a variety of environmental and genetic factors. The periodontal tissue damage is caused directly by bacteria and indirectly by inflammation and immune response against bacteria (McDevitt et al, 2000) .
According to Chapple and Matthews (2007),
this hyper inflammatory response fails to remove the causative pathogens and also generates a prolonged release of neutrophil proteolytic enzymes, pro-inflammatory mediators and reactive oxygen species (ROS), which in turn destroy the periodontal attachment. Fusobacterium nucleatum and periodonto-pathogens can induce an increased intracellular production of ROS in neutrophils along with their release.
Therefore, periodontal diseases are strictly linked to numerous pathologies related to the production of oxidative stress (Szczepanski et al, 2007) and AGEs (Allen et al, 2009) . Accordingly, the present study was conducted to find out the role of AGEs and the valuable use of its crevicular level over the serum level in the diagnosis and prognosis of periodontitis after nonsurgical periodontal therapy.
SUBJECTS AND METHODS
Thirty participants, 21 females, and 9 males (ranging in age from 35-60) years were included in the study. They were selected from outpatient clinic of Oral Medicine, and Periodontology Department, Faculty of Dentistry, Cairo University. The study was conducted from Jan 2015 to Sep 2017.
They were divided to the following two groups:
Group (1): included 15 healthy participants free of any systemic diseases according to the modification of Cornell medical index (Abramson JH 1966.) Group (2): included 15 patients of periodontitis and free of any other systemic diseases according to Cornell medical index (Abramson JH 1966.) All participants were informed of the objectives and nature of the study and showed willingness to come for the follow up visits till the end of the study. They were given written approval consent to sign.
Inclusion criteria
Age ≥ 35 years and a minimum of 20 natural teeth, not including third molars
As for patients with periodontitis, participants with moderate to severe periodontitis having gingival index GI ≥ 1, probing depth PD ≥ 5, and clinical attachment level CAL ≥ 4 mm, and bone loss affecting > 30% of existing teeth on clinical/ radiographic examination according to the American academy of periodontology 2000 were included in the study.
Exclusion criteria
Periapical pathologies, exposure to mechanical force as a result of occlusion/ orthodontics, and any systemic disease such as, human immunedeficiency virus, cancer, diabetes mellitus, or any other diseases which may affect the biomarkers levels and the periodontal conditions, smoking over the past 5 years, exposure to steroid therapies, radiation/immune-suppressive therapies, allergic reaction to any kind of drugs. Participants featured no history of either periodontal or drug therapies within the preceding 6 months, such as antibiotic courses, anti-inflammatory treatments, or other pharmacological treatments.
Periodontal examination
At baseline, all participants were subjected to a full-mouth examination. For periodontitis patients, clinical parameters were recorded, including (plaque index PI, GI, PD, and CAL). Again, these parameters were recorded 3 months following scaling and root planning (SRP) for group 2 participants. PD and CAL were measured using a Williams's periodontal probe (Hu-Friedy, Chicago, IL, USA). Individuals were assessed twice with a 48-h interval. If the difference between the two measurements fall within a < 10% mm range, then researcher measurements were considered to be acceptable (Schwarz et al, 2006) .
Periodontal treatment
Once baseline crevicular samples were taken, individuals with periodontitis were subjected to non-surgical periodontal treatment, SRP using manual scalers and curettes with local anaesthesia. Periodontal treatment was completed in 2-3 visits for 2 weeks according to each patient's requisites, and each visit was 45-60 min long. No pharmacological interventions were prescribed as part of the course of treatment; they only were given oral hygiene instructions, using the modified Bass approach, toothpaste, and interdental tools.
Samples collection and analysis

1-Site Selection and GCF Collection:
Clinical and radiologic examinations and sampling site selections were conducted by a single examiner. Samples were gathered the day after patients had been given clinical assessment. Thus to avoid mixing GCF and blood associated with the probing at inflamed areas. Two sites per individual were chosen from each group. GCF samples were taken from mesio-buccal or disto-buccal sites outside of single-rooted teeth. Samples were taken at baseline from the two groups and 6 weeks after SRP for periodontitis group. For periodontitis group; GCF sample was taken from the areas with the most prominent clinical indications of inflammation (the highest GI score and BOP) and the highest PD with radiographic readings of bone loss. For healthy groups, GCF samples were acquired from areas that showed no clinical inflammation (GI = 0, without BOP). Before crevicular sampling, all supra gingival plaque was eliminated from the sample area with a sterile cotton roll. The site was then washed with water then sectioned off with cotton balls, and gradually air-dried to avoid salivary contamination. Paper strips were positioned inside the crevice until a small amount of resistance was encountered then allowed to remain in place for 30 seconds (Griffiths, 2003) . This process was conducted very gently to prevent manual damage to gingival tissues. The degree of GCF on the strips was calculated by weighing the collected liquid. The strips were put into closed and numbered plastic micro-centrifuge cases, and then liquid was weighed again, immediately after collection, to take evaporation into account (Tu¨ter et al, 2010) . Samples contaminated with blood and saliva were disregarded. Two strips from each study participant were put into a single (coded) Eppendorf container and combined to form one sample, and quickly stored at -80C until they could be evaluated.
2-Serum collection
Venous samples were obtained to measure the serum level of AGEs using the ELISA technique after 12 h of fasting. Blood samples were collected in sterile tubes and allowed to clot at room temperature. Sera were isolated by centrifugation and stored frozen below −20 until assayed for the AGEs level.
Measurement of AGE level in GCF:
The level of AGE was measured using the sandwich Enzyme-Linked Immunosorbent Assay (ELISA) kit. The kit was provided by Bioassay Technology Laboratory, Shanghai, CHINA. AGEs was added to the wells which were pre-coated with AGEs monoclonal antibody. Then, after cubation, a biotin-conjugated anti-human AGEs antibody was added to bind to human AGEs. After incubation, unbound biotin-conjugated anti-human AGEs antibody was washed away during a washing step. Next step was addition of Streptavidin-HRP to bind to the biotin-conjugated anti-human AGEs antibody. After incubation unbound Streptavidin-HRP was washed away during a washing step. The Substrate solution was then added and the color developed in proportion to the amount of human AGEs. Finally, the reaction was terminated by addition of acidic stop solution and absorbance was measured at 450 nm.
Statistical analysis:
Numerical data were explored for normality by checking the distribution of data and using tests of normality (Kolmogorov-Smirnov and Shapiro-Wilk tests). Age, Pocket Depth (PD), Clinical Attachment Level (CAL), serum and GCI Advanced Glyacation product (AGE) levels data showed normal (parametric) distribution while Gingival Index (GI) and Plaque Index (PI) data showed non-normal (nonparametric) distribution. Parametric data were presented as mean, standard deviation (SD) and 95% Confidence Interval (95% CI) for the mean values while non-parametric data were presented as median and range values. For parametric data, Student's t-test was used to compare between age values in the two groups. Paired t-test was used to study the changes after treatment in PD and CAL. Repeated measures ANOVA test was used to compare between AGE levels in the two groups as well as the changes within each group. Bonferroni's post-hoc test was used for pair-wise comparisons when ANOVA test is significant. Pearson's correlation coefficient was used to determine the correlation between PD, CAL and AGE levels. For non-parametric data; Wilcoxon signed-rank test was used to study the changes after treatment in GI. Spearman's correlation coefficient was used to determine the correlation between GI and AGE levels. Qualitative data were presented as frequencies and percentages. Fisher's Exact test was used for comparisons between the groups. The significance level was set at P ≤ 0.05. Statistical analysis was performed with IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.
Demographic data:
There was no statistically significant difference between mean age values in the two groups. There was also no statistically significant difference between gender distributions in the two groups. 
Clinical parameters
Changes after treatment in Periodontitis group
There was a statistically significant decrease in Probing Depth (PD) (P-value <0.001, Effect size = 1.629), Clinical Attachment Level (CAL) (P-value <0.001, Effect size = 1.927), Plaque Index (PI) (P-value = 0.024, Effect size = 0.800) and Gingival Index (GI) (P-value = 0.010, Effect size = 0.914).
Advanced Glyacation product (AGE) levels
Comparison between the two groups
In serum either before or after treatment, Periodontitis group showed statistically significantly higher mean AGE levels than control group (P-value <0.001, Effect size = 0.709) and (P-value = 0.014, Effect size = 0.361), respectively.
Similarly in GCF either before or after treatment, Periodontitis group showed statistically significantly higher mean AGE levels than control group (P-value <0.001, Effect size = 0.683) and (P-value = 0.007, Effect size = 0.414), respectively.
Changes after treatment in Periodontitis group
Whether in serum or GCF, there was a statistically significant decrease in AGE level after treatment (P-value <0.001, Effect size = 0.775) and (P-value <0.001, Effect size = 0.785), respectively. 
Correlation between clinical parameters and Advanced Glyacation product (AGE) levels in Periodontitis group
There was no statistically significant correlation between different clinical parameters and AGE levels before or after treatment except for the correlation between PI and AGE level in GCF before treatment where there was a statistically significant inverse correlation between PI and AGE levels (Spearman's' rho "ρ" = -0.848, P-value = 0.008) indicating that an increase in PI is associated with a decrease in AGE GCF levels and vice versa. 
DISCUSSION
AGEs are known to affect nearly every type of cell and molecule in the body, which have pathogenic role in some conditions that causes intracellular damage and apoptosis. Recent studies have done work aiming for the treatment and prevention of related complications to some disorders including aging, kidney failure, diabetes, Alzheimer's disease, coronary artery disease, and osteoarthritis. These studies demonstrated that most of the complications especially in diabetic patients are mostly due to the accumulation of AGEs (Singh et al, 2011) .
The hyper inflammatory response in periodontitis is characterized by prolonged release of neutrophil proteolytic enzymes, pro-inflammatory mediators and reactive oxygen species (ROS) (Chapple and Matthews, 2007) which play the major role in destruction of the periodontal attachment. Fusobacterium nucleatum and periodonto-pathogens are known to induce an increased intracellular production of ROS in neutrophils along with their release (Tsai, et al, 2005) .
The direct evidence for the presence of AGEs in the periodontal ligament is still lacking, on the other hand, valuable approaches based on the use of periodontal cells along with genetic and bio-chemical studies in animal models and chronic periodontal patients support a potential role for protein glycation in the aetiology and severity of periodontitis (Pietropaoli et al, 2010) .
Regarding both gender distributions and mean age values, the present study showed no statistically significant difference in the two groups. These results are in accordance with Zizzi et al, (2013) , based on these results; age did not correlate significantly with crevicular level of AGE levels in any of their study groups; this finding was unexpected given that sample data which have shown age to be one of the decisive factors in AGEs accumulation in various organs as reported by Sato et al, 2001 .
As regard to the clinical changes after treatment in periodontitis group, the present study detected a statistically significant decrease in probing depth (PD), clinical attachment level (CAL), and gingival index (GI).These results are in agreement with (Khushboo et al, 2017) and (Nobre et al, 2019) .
Considering Advanced Glyacation end product (AGE) levels, the serum level either before or after treatment; the periodontitis group showed statistically significantly higher mean AGE levels than control group respectively. These results are similar to the results obtained by Takeda et al , (2006) who revealed that serum AGEs levels were significantly associated with deterioration of periodontitis, accordingly, they suggested AGEs as a useful biomarkers that reflect periodontal deterioration. Up to author's knowledge, there are very few studies that explored the serum level of AGEs. Due to the potential diagnostic importance of gingival crevicular fluid, the present study focused the light on the crevicular level of AGEs especially that, up to author's knowledge, no other studies explored the crevicular level of AGEs. The current study detected a statistically significantly higher mean AGE levels in the periodontitis group than control group either before or after treatment, respectively. This can be explained by accumulation of AGEs in periodontal tissues and their role in the microvascular alterations as found in diabetic patients as reported by Schmidt et al, (1996) , where AGEs are known to bind irreversibly to collagen forming macro-molecules which accumulate in the basement membranes of endothelial cells resulting in increased basement membrane thickness and alteration in the normal homeostatic transport across the membrane as mentioned by Seppala & Ainamo (1994) .
Recently, Allen et al. in 2011 proposed that the hyperactive neutrophils, which possibly activated within the periodontium, maybe an important source of reactive oxygen species which in turn activate the pro-inflammatory pathways and then promote insulin resistance in patients with periodontitis and diabetes.
The increased oxidative stress plays a major role in elevated lipid peroxidation which in turn may have a pro-inflammatory effect. Bastos et al. in 2012 demonstrated higher levels of GCF markers of lipid peroxidation in diabetes patients which correlated with both the clinical parameters of periodontitis and levels of inflammatory mediators.
On the same hand, AGEs were found to have an adverse effect on bone collagen at the cellular level and this may explain the alterations in bone metabolism (Vashisht, 2001) and (Monnier et al, 2005) .
In addition, Glycation of the bone collagen was found to affect the bone turnover, inducing reduced bone formation which in turn, reduces osteoblastic differentiation and ECM production (Gunczler et  al, 2001) and (McCarthy et al, 2001) .
Later on, AGEs were found to participate in the pathogenic mechanisms of periodontitis independently of the mechanisms underlying their accumulation (Pietropaoli et al, 2010) .
Regarding the changes after treatment in Periodontitis group, whether in serum or GCF, the current study revealed a statistically significant decrease in AGEs level after treatment respectively. This can be explained by the effect of periodontal treatment which not only reduces the oral inflammation, but also decreases the systemic levels of different inflammatory makers such as IL-6, TNF-α, and C-reactive proteins (CRP), indicating that periodontal diseases induce systemic alterations beyond the local periodontal environment (D'Aiuto,  et al, 2004) .
The present study detected no statistically significant correlation between different clinical parameters and AGE levels before or after treatment in periodontitis patients.
Based on the observations of included studies, and on the results of the current study, it can be concluded that GCF is an effective and efficient prognostic tool by means of analysis of variations in constituents before and after periodontal therapy (Stuti et al, 2018) .
Accordingly, crevicular level AGE can be used as a biomarker for the diagnosis and prognosis of periodontitis.
Finally, it is recommended to conduct larger and long-term studies in the future, as one of the limitations of the current study is the small sample size. The small period of follow up is another limitation.
CONCLUSION
Crevicular level of AGE can be used as a noninvasive diagnostic and prognostic biomarker for periodontitis.
